跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Rabegen - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Rabegen
Approved
STANDARD
Rabegen
Inventia Healthcare Pvt., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
42db28d95a2e8fc2
Company
Inventia Healthcare Pvt., Ltd.
Type
Standard
Approval Details
Approval Id
42db28d95a2e8fc2
Drug Approval Philippines Name
Rabegen
Product Name
Rabegen
Registration Number
DR-XY45609
Brand Name
Rabegen
Generic Name
Rabeprazole Sodium + Itopride Hydrochloride
Dosage Form
Modified Release Capsule
Dosage Strength
20 mg/150 mg
Manufacturer
Inventia Healthcare Pvt., Ltd.
Importer
I.E. Medica Inc.
Distributor
Innogen Pharmaceuticals, Inc.
Issuance Date
24 November 2022
Expiry Date
24 November 2026
Pharmacologic Category
Proton pump Inhibitor
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
42db28d95a2e8fc2
Type
Standard
Back to Philippines FDA Approvals